|
Pharma Marketing Talk is hosted by John Mack, the creator of Pharma Marketing Blog and Publisher of Pharma Marketing News.
We accept advertising relevant to the interests of our members. For more information, see: Operated by: VirSci Corporation PO Box 760 Newtown, PA 18940 215-504-4164 215-504-5739 (FAX) E-mail: infovirsci@virsci.com |
![]() About Pharma Marketing Talk | List of Shows | Schedule and Archives | FAQs
Marketing to the "Long Tail Physician" Segment
An audio archive is available after the show here. You may also click on a button below to listen to the streaming audio archive on your computer or to download the archived show for playback on your iPod or other portal audio player
There are numerous examples of how the long tail concept might play out in healthcare. One can see a day where a pharma brand manager doesn't use prescription volume as the key determinant in segmenting physicians.
The implications are tremendous.
Paul Boidy knows from experience with many different brands that 50% of the total market for prescriptions come from prescribers OUTSIDE of the highly targeted top 20%. With new and yet to be developed communications and education platforms marketers will be able to cost-effectively reach a significant portion of the other 80%. That would be good for everyone.
Boidy sometimes gets asked where are the additional resources for these programs going to come from. His answer: from the savings made by reducing the number of sales reps who are bumping into each other all trying to compete for the same 20%.
Some Questions/Topics to be Discussed
Paul started his
career at Searle Pharmaceuticals and held increasing
positions of responsibility there and with other
companies in sales, operations, marketing, and
strategic planning. Paul was directly involved in
the planning and launch of many successful
pharmaceutical brands.
Paul has worked closely with physician
and patient associations such as the National Sleep
Foundation, the American Geriatric Society, and
the American Psychiatric Association to develop
programs dedicated to improving public health.
|
© 2007 VirSci Corporation. All rights reserved.